Research and development for the manufacturing of monoclonal antibodies

2 PhD and 2 postdoc positions available in Biotechnology

Therapeutic strategies involving monoclonal antibodies are increasingly prevalent. The desire to reduce the
cost of these drugs is exerting considerable pressure to make the manufacturing process more efficient and
cost effective. Presently, purification of the antibody from the production medium has become a major
process bottleneck. Another major bottleneck for scaling-up the manufacturing of monoclonal antibodies is
the high viscosity of their solutions.
The Gauthier group is looking to strategically hire 2 PhD students and 2 postdocs to work on these
important challenges. Candidates with backgrounds in chemistry, biochemistry, bio-conjugate chemistry,
polymer chemistry, pharmaceutical science, analytical chemistry, or physical chemistry are most suited for
the foreseen projects. However, candidates with other backgrounds will be considered. Successful
candidates will have the opportunity to engage in research in both academic and industrial environments.
Stipends are competitive and performance-incentives (bonuses) are possible. Furthermore, the group
offers generous stipend top-ups for externally-funded students and postdocs (i.e., scholarship holders).
The Gauthier group is housed at the EMT Research Center of INRS, approx. 25 km from vibrant downtown
Montreal. INRS has been consistently recognized by Research Info$ource as the #1 or #2 university in
Canada for research intensity, which is an important yet indirect indicator of the quality of its research
programs.

Interested candidates should send their CVs to: gauthier@emt.inrs.ca

Group website: http://www.inrs.ca/marc-gauthier